
Declining China Dat...


| Price and Volume | |
|---|---|
| Recent Price | 36.50 |
| 52 Week High | 44.53 |
| 52 Week Low | 30.87 |
| Avg. Daily Vol. (Mil) | 0.23 |
| Beta (3 year) | 0.90 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,024.36 |
| Shares Out (Mil) | 28.06 |
| Float (Mil) | 16.54 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.90 |
| Current Ratio | 4.20 |
| LT Debt/ Equity | 1.02 |
| Total Debt / Equity | 1.02 |
| Valuation Ratios | |
| Price Earnings | 34.40 |
| Price/Sales | 1.23 |
| Price/Book | 2.01 |
| Price/Cash Flow | 11.20 |
| Per Share Data | |
| Earnings | 1.06 |
| Sales | 29.62 |
| Book Value | 18.17 |
| Cash Flow | 3.25 |
| Business Summary | |
|---|---|
| Integra LifeSciences Holdings Corporation is a medical device company, which is engaged in the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. | |
| General Information | |
| 311 Enterprise Drive
Plainsboro, NJ 08536 |
|
| www.integralife.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 3500 | |
| CEO: Peter J. Arduini | |
| Short Interest | |
| Current Month (Mil) | 1.02 |
| Previous Month (Mil) | 1.12 |
| Short Interest Ratio (Days) | 3.40 |
| Management Effectiveness | |
| Return on Equity | 7.30 |
| Return on Assets | 3.20 |
| Return on Investments | 3.60 |
| Profitability | |
| Gross Margin | 65.90 |
| EBIT Margin | 6.70 |
| Profit Margin | 4.50 |